Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Vaccine trial participant and CNN correspondent's big reveal. Was it the placebo or the real thing?

Vaccine trial participant and CNN correspondent's big reveal. Was it the placebo or the real thing?

CNN
Tuesday, March 23, 2021 12:50:19 PM UTC

Months after CNN correspondent Stephanie Elam started the vaccine trial, she finds out if she really got the J&J shot.

But this appointment is going to be different. Since my last check-up, Johnson & Johnson has been granted emergency use authorization for its single-shot Covid vaccine. As a thank you for those of us who participated in the randomized, phase three vaccine trial, the company is unblinding participants and administering the vaccine to the placebo group. I am looking forward to this unblinding with the same exuberance I had as a kid the week of Christmas. All of those presents under the tree just waiting to be opened! But this time, my present is protection against a deadly virus -- an inoculation that is literally saving lives.
Read full story on CNN
Share this story on:-
More Related News
CIA assesses Ukraine was not targeting a Putin residence in drone attack, contrary to Kremlin claim, sources say

The CIA has assessed Ukraine was not targeting a residence used by Russian President Vladimir Putin in a recent drone attack in the north of his country, according to US officials, undercutting an assertion the Russian president had made to Trump in a Monday phone call.

In evolving Latin America, US-Venezuela discord remains a constant

The following is a deep look at contemporary Venezuela, its history, its riches, its alliances and its delicate internal balance of power amid growing tensions with the US.

CIA assesses Ukraine was not targeting a Putin residence in drone attack, contrary to Kremlin claim, sources say

The CIA has assessed Ukraine was not targeting a residence used by Russian President Vladimir Putin in a recent drone attack in the north of his country, according to US officials, undercutting an assertion the Russian president had made to Trump in a Monday phone call.

© 2008 - 2026 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us